MedTrace Logo

Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19

NCT04764747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-06-02

No results posted yet for this study

Summary

Multicenter retrospective cohort study from June to August 2020 on hospitalized COVID-19 patients admitted to Al-Hakeem and Al-Amal hospital in Al-Najaf Governorate, Iraq, in order to evaluating the effectiveness of plasma therapy in hospitalized patients with COVID-19 and analyzing factors that affect therapeutic outcome, either related to patients or related to donors.

Conditions

  • Covid19

Sponsors & Collaborators

  • Kufa University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-04-25
Completion
2021-04-25

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04764747 on ClinicalTrials.gov